Aspire Wealth Management Corp Pfizer Inc Transaction History

Aspire Wealth Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $2,727 - $3,188	-85 Reduced 1.34%	6,276 $208,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $1,083 - $1,253	-30 Reduced 0.47%	6,361 $233,000
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $236 - $307	-6 Reduced 0.09%	6,391 $260,000
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $41 - $54	-1 Reduced 0.02%	6,397 $327,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $131 - $160	3 Added 0.05%	6,398 $280,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $4,513 - $5,351	-97 Reduced 1.49%	6,395 $335,000
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $8,921 - $11,054	-195 Reduced 2.92%	6,492 $336,000
Q4 2021 Mar 14, 2022	BUY	$41.32 - $61.25 $276,306 - $409,578	6,687 New	6,687 $395,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Aspire Wealth Management Corp, based on Form 13F filings with the SEC.

Stay updated on Aspire Wealth Management Corp with notifications on news.